Latest news
Four new employees get options for 115,250 Cartesian shares - Stock TitanStock Titan · Fri, 07 Aug 2026 11:00:00 GMTCartesian Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 14:48:34 GMTCartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTCartesian Therapeutics reports Q2 2026: $149.3M cash; net income $15.8M; Phase 3 MG data expected 1Q27 - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTCartesian Therapeutics (Nasdaq: RNAC) Q2 earnings boosted by CVR revaluation - Stock TitanStock Titan · Thu, 06 Aug 2026 11:06:28 GMTCartesian Therapeutics (NASDAQ:RNAC) Raised to Hold at Zacks Research - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMT